CURA_1170x120_8-22-19

Diplomat Pharmacy

Diplomat signs exclusive practice-based infusion agreement with Allergy Partners

Diplomat signs exclusive practice-based infusion agreement with Allergy Partners

FLINT, Mich. — Diplomat Pharmacy announced an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office and in-home delivery and administration of infusion drugs and biologics. The agreement will cover treatments for primary immunodeficiency, alpha-1 antitrypsin deficiency, hereditary angioedema, and more. Allergy Partners is the nation’s largest independent, single-specialty practice for allergic disease,

Diplomat announces second quarter results, to review strategic alternatives

Diplomat announces second quarter results, to review strategic alternatives

FLINT, Mich. — Diplomat Pharmacy announced financial results for the quarter ended June 30, 2019.   Revenue decreased 9% from $1.4 billion to $1.2 billion and gross profit decreased from $98.4 million to $72.7 million from the prior-year quarter. Adjusted EBITDA was $19.3 million compared to $42.7 million in the prior-year period, and earnings per share were

Diplomat names Daniel Davison as CFO

Diplomat names Daniel Davison as CFO

FLINT, Mich. — Diplomat Pharmacy announced Friday that the company’s board of directors has appointed Dan Davison as chief financial officer and treasurer effective April 8, succeeding Atul Kavthekar. Davison will report to Brian Grin, Diplomat’s chairman and chief executive officer and will lead the company’s finance function, which is expected to be streamlined under

Diplomat partners with CSI Specialty Group to expand health system services

Diplomat partners with CSI Specialty Group to expand health system services

FLINT, Mich. — Diplomat Pharmacy and CSI Specialty Group, a globally recognized specialty pharmacy consulting firm, have launched a program for hospitals and health systems interested in starting or expanding their own specialty pharmacy services to benefit from Diplomat’s limited-distribution drug portfolio and expertise treating rare, chronic, and complex diseases. CSI, a partner of leading national healthcare

Diplomat provides updated 2018 guidance and preliminary 2019 outlook

Diplomat provides updated 2018 guidance and preliminary 2019 outlook

FLINT, Mich. — Diplomat Pharmacy is updating its 2018 financial guidance and providing a preliminary 2019 outlook in connection with its presentation today at the JP Morgan Healthcare Conference in San Francisco. Diplomat now expects 2018 revenue to be at the lower end of the previously communicated $5.5 to $5.7 billion range and adjusted EBITDA to be at

Diplomat opens facility in Arizona

Diplomat opens facility in Arizona

FLINT, Mich. — Diplomat Pharmacy  has opened a 75,000-square-foot facility in Chandler, Ariz., to bolster pharmacy operations and ensure business continuity. Diplomat expects the location to create 200 local jobs over the next year. Chief executive officer and chairman Brian Griffin said the Chandler facility — 485 N. Juniper Drive — increases Diplomat’s capacity to serve more

Diplomat announces 2nd quarter financial results

Diplomat announces 2nd quarter financial results

FLINT, Mich. — Diplomat Pharmacy announced financial results for the quarter ended June 30, 2018.  All comparisons, unless otherwise noted, are to the quarter ended June 30, 2017.  Prior period financials have been recast to include certain direct expenses as part of cost of sales instead of selling, general and administrative expense (“SG&A”) for our specialty

Diplomat Pharmacy names Griffin CEO

Diplomat Pharmacy names Griffin CEO

FLINT, Mich.— Diplomat Pharmacy Inc. announced that its board of directors has appointed Brian Griffin, executive vice president and chief executive officer of IngenioRx, the pharmacy benefit manager (PBM) of Anthem, as chief executive officer and chairman of the board of directors, effective June 4. Ben Wolin, chairman of the board, said, “We are pleased to

Diplomat launches CastiaRx, leading specialty benefit manager

Diplomat launches CastiaRx, leading specialty benefit manager

FLINT, Mich. — Diplomat Pharmacy has unveiled CastiaRx to respond to industry demand for a leader in specialty benefit management. CastiaRx unites the full-service pharmacy benefit manager (PBM) capabilities of recently acquired LDI Integrated Pharmacy Services and National Pharmaceutical Services with Diplomat’s specialty pharmacy and infusion expertise. According to the IQVIA Institute for Human Data

Diplomat works to control specialty drug costs

Diplomat works to control specialty drug costs

FLINT, Mich. — Biosimilars, generic drugs and affordable branded drugs are top-of-mind at Diplomat Pharmacy Inc. this year as the specialty pharmacy looks to help health plans and patients rein in costs. According to Diplomat president Joel Saban, the surging market for expensive specialty drugs has put pressure on stakeholders across the health care sector.

Diplomat CEO Phil Hagerman to retire

Diplomat CEO Phil Hagerman to retire

FLINT, Mich. — Phil Hagerman, co-founder, chairman and chief executive officer of Diplomat Pharmacy Inc., the nation’s largest independent specialty pharmacy, plans to retire. Diplomat said Friday that board member Jeff Park has been named interim CEO, and independent lead director Ben Wolin has been appointed chairman. Both moves are effective immediately. Diplomat’s board has launched

1 2 3 4